The number of anti-vaccine bills filed in Texas has risen, yet many Texans support vaccine policy. Fellow Kirstin R.W. Matthews and nonresident scholar Rekha Lakshmanan examine the stakes of legislative engagement in public health initiatives and provide a call to action for Texans to embrace public health as an act of freedom.
“Nearly one billion travelers pass through U.S. airports each year,” writes Alicia L. Johnson, civic science postdoctoral associate. In a new commentary, she outlines how the CDC’s genomic surveillance program, which monitors airport wastewater for traces of infectious disease, must balance public health and privacy concerns.
The work of Katalin Karikó, 2023 Nobel Prize in Medicine recipient, laid a foundation for the development of COVID-19 mRNA vaccines that saved close to 20 million lives worldwide. But her discoveries almost did not happen, writes Alicia L. Johnson, a civic science postdoctoral associate at the Baker Institute Center for Health and Biosciences. Karikó’s story highlights the vital importance of supporting women in STEM.
"This is a moment to prioritise health over short-term political calculations," write fellow Peter Hotez, Rekha Lakshmanan and nine other experts in a Lancet commentary. Click here for their call for action against anti-vaccine rhetoric and COVID-19 misinformation, and five short-term recommendations.
Rekha Lakshmanan, Peter J. HotezSeptember 17, 2021
An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.
Once the Covid-19 pandemic has subsided, the new Israeli government will face serious flaws in, among other things, the territorial dimensions of President Trump's “Deal of the Century,” writes Middle East fellow Gilead Sher for the Baker Institute blog: https://bit.ly/2VvkBPw
"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.
